The increasing prevalence of type 2 diabetes (T2D) and its complications challenge our healthcare delivery systems. Indeed, the healthcare industry is vulnerable to the rising costs and faces challenges with respect to increased life expectancy and prevalence of chronic diseases. Adults with T2D often have limitations in mobility and experience increased risk of physical disability.1
Furthermore, the number of obese older adults with T2D has substantially increased in the last 20 years.2
Obesity among older adults is problematic because it not only increases the risk of medical complications but also causes physical dysfunction.3
Functional limitations associated with obesity and T2D exacerbate the age-related decline in physical function, and begin a slippery slope of negative consequences such as frailty, impaired quality of life (QOL) and increased institutionalisation.4
To date, limited data exist regarding the efficacy of lifestyle intervention in preventing functional decline in this population.